Maria Maddalena Angioni
Immunotherapy and Cancer: The Multi-Omics Perspective
Clelia Donisi
First
Data Curation
;Andrea PrettaSecond
Writing - Review & Editing
;Valeria Pusceddu;Pina Ziranu;Marco Puzzoni;Elena MassaSupervision
;Clelia Madeddu and Mario Scartozzi
2024-01-01
Abstract
Immunotherapies have revolutionized cancer treatment approaches. Because not all patients respond positively to immune therapeutic agents, it represents a challenge for scientists who strive to understand the mechanisms behind such resistance. In-depth exploration of tumor biology, using novel technologies such as omics science, can help decode the role of the tumor immune microenvironment (TIME) in producing a response to the immune blockade strategies. It can also help to identify biomarkers for patient stratification and personalized treatment. This review aims to explore these new models and highlight their possible pivotal role in changing clinical practice.File | Size | Format | |
---|---|---|---|
Donisi et Al.pdf open access
Description: Articolo principale
Type: versione editoriale
Size 288.49 kB
Format Adobe PDF
|
288.49 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.